GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LigaChem Biosciences Inc (XKRX:141080) » Definitions » Total Liabilities

LigaChem Biosciences (XKRX:141080) Total Liabilities : ₩137,359 Mil (As of Mar. 2024)


View and export this data going back to 2013. Start your Free Trial

What is LigaChem Biosciences Total Liabilities?

LigaChem Biosciences's Total Liabilities for the quarter that ended in Mar. 2024 was ₩137,359 Mil.

LigaChem Biosciences's quarterly Total Liabilities increased from Sep. 2023 (₩37,304.71 Mil) to Dec. 2023 (₩41,280.91 Mil) and increased from Dec. 2023 (₩41,280.91 Mil) to Mar. 2024 (₩137,358.64 Mil).

LigaChem Biosciences's annual Total Liabilities declined from Dec. 2021 (₩34,458.71 Mil) to Dec. 2022 (₩32,931.52 Mil) but then increased from Dec. 2022 (₩32,931.52 Mil) to Dec. 2023 (₩41,280.91 Mil).


LigaChem Biosciences Total Liabilities Historical Data

The historical data trend for LigaChem Biosciences's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LigaChem Biosciences Total Liabilities Chart

LigaChem Biosciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 25,568.11 23,786.16 34,458.71 32,931.52 41,280.91

LigaChem Biosciences Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 34,447.59 32,165.78 37,304.71 41,280.91 137,358.64

LigaChem Biosciences Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

LigaChem Biosciences's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=37071.716+(528.373+3.9109999999964
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+3676.912)
=41,281

Total Liabilities=Total Assets (A: Dec. 2023 )-Total Equity (A: Dec. 2023 )
=189502.179-148221.267
=41,281

LigaChem Biosciences's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=131327.296+(128.671+5.1619999999966
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+5897.507)
=137,359

Total Liabilities=Total Assets (Q: Mar. 2024 )-Total Equity (Q: Mar. 2024 )
=765096.751-627738.115
=137,359

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


LigaChem Biosciences Total Liabilities Related Terms

Thank you for viewing the detailed overview of LigaChem Biosciences's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


LigaChem Biosciences (XKRX:141080) Business Description

Traded in Other Exchanges
N/A
Address
8-26 Munpyeongseo-ro, Daedeok-gu, Daejeon, KOR, 34302
LegoChem Biosciences Inc develops new drugs through research. The Company provides business research services, manufacturing and sale of compounds, and drug evaluation.

LigaChem Biosciences (XKRX:141080) Headlines

No Headlines